FGH BioTech is committed to developing small molecule drugs For Good Health that regulate SREBP transcription factors and related pathways for the prevention and treatment of metabolic diseases and cancer.

Our mission is driven by over 60 years of groundbreaking discoveries in fat and energy metabolism by our company’s founders.

Learn more about Our Technology